PET/MR Imaging in the Evaluation of Lymphomas and Post-Transplant Lymphoproliferative Disorder in Pediatric Patients.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
Pediatric lymphoma (PL) is the third most common malignancy to affect children, seen in up to 15% of children, after leukemia and central nervous system tumors. SEER data from 1975 - 2019 has shown an increase in the incidence of childhood cancer including leukemia and lymphomas. Fortunately, there has been an increase if the 5-year overall survival of PL. 18F-Fluordeoxyglucose PET imaging plays an important role in the diagnosis, staging and response to therapy in pediatric lymphomas. This review will focus on the incorporation of PET/MR into the standard treatment of children with PL.